H. Fuke

发表

Role of poly (A) tail as an identity element for mRNA nuclear export

M. Ohno, H. Fuke, 2007, Nucleic acids research.

Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases.

K. Shiraki, T. Nakano, K. Sugimoto, 2005, Human pathology.

Sarcomatous hepatocellular carcinoma with remittent fever.

K. Shiraki, Y. Takei, K. Sugimoto, 2012, Internal medicine.

1.5 Harmonic Imaging Sonography with microbubble contrast agent improves characterization of hepatocellular carcinoma.

K. Shiraki, T. Nakano, Kouji Yamamoto, 2005, World journal of gastroenterology.

Corona enhancement in ultrasonographical post-vascular phase images with microbubble contrast agent: a novel specific sign for hepatocellular carcinomas.

K. Shiraki, Kouji Yamamoto, H. Fuke, 2006, Oncology reports.

Type 1 Diabetes Mellitus Provoked by Peginterferon α -2b Plus Ribavirin Treatment for Chronic Hepatitis C

K. Shiraki, Y. Takei, K. Sugimoto, 2008 .

Type 1 diabetes mellitus provoked by peginterferon alpha-2b plus ribavirin treatment for chronic hepatitis C.

K. Shiraki, Y. Takei, K. Sugimoto, 2008, Internal medicine.

Tubulointerstitial nephritis associated with IgG4-related autoimmune disease.

K. Shiraki, Shinsuke Nomura, E. Ishikawa, 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Dual topology of functional Toll-like receptor 3 expression in human hepatocellular carcinoma: differential signaling mechanisms of TLR3-induced NF-kappaB activation and apoptosis.

K. Shiraki, Y. Takei, K. Sugimoto, 2008, International journal of oncology.

Adenovirus-mediated transfection of caspase-8 sensitizes hepatocellular carcinoma to TRAIL- and chemotherapeutic agent-induced cell death.

K. Shiraki, T. Nakano, Y. Yamaguchi, 2006, Biochimica et biophysica acta.

Proteasome inhibition sensitizes hepatocellular carcinoma cells to TRAIL by suppressing caspase inhibitors and AKT pathway

K. Shiraki, T. Nakano, K. Sugimoto, 2006, Anti-cancer drugs.

The cyclin-dependent kinase inhibitor flavopiridol sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis.

K. Shiraki, T. Nakano, K. Sugimoto, 2006, International journal of molecular medicine.

Clinical utility of transarterial infusion chemotherapy using cisplatin-lipiodol emulsion for unresectable hepatocellular carcinoma.

K. Takeda, H. Takaki, K. Yamakado, 2012, Anticancer research.

Splenectomy rescues patients of liver cirrhosis with hypersplenism from liver failure

K. Shiraki, T. Nakano, K. Sugimoto, 2006 .

Lamivudine for treatment of spontaneous exacerbation and reactivation after immunosuppressive therapy in patients with hepatitis B virus infection.

K. Shiraki, N. Yamamoto, H. Fuke, 2007, Hepato-gastroenterology.

Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas larger than 5 cm.

K. Takeda, H. Takaki, K. Yamakado, 2009, Journal of vascular and interventional radiology : JVIR.

Cervical mycotic aneurysm in a patient with alcoholic cirrhosis.

K. Shiraki, Y. Takei, J. Tanaka, 2007, Internal medicine.

Treatment of traumatic pancreatic duct disruption with an endoscopic stent.

K. Shiraki, T. Nakano, H. Fuke, 2003, Pancreas.

Cardiac metastases of gallbladder carcinoma.

K. Shiraki, T. Nakano, K. Sugimoto, 2005, World journal of gastroenterology.

Different effects of bile acids, ursodeoxycholic acid and deoxycholic acid, on cell growth and cell death in human colonic adenocarcinoma cells.

K. Shiraki, K. Takase, T. Nakano, 2005, International journal of molecular medicine.

Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy.

K. Takeda, H. Takaki, K. Yamakado, 2008, Radiology.

Targeting of X-linked inhibitor of apoptosis protein or survivin by short interfering RNAs sensitize hepatoma cells to TNF-related apoptosis-inducing ligand- and chemotherapeutic agent-induced cell death.

K. Shiraki, T. Nakano, K. Sugimoto, 2005, Oncology reports.

Jak inhibitor induces S phase cell-cycle arrest and augments TRAIL-induced apoptosis in human hepatocellular carcinoma cells.

K. Shiraki, Y. Takei, K. Sugimoto, 2007, Biochemical and biophysical research communications.

COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis.

K. Shiraki, T. Nakano, K. Sugimoto, 2006, International journal of molecular medicine.

Protective role of interleukin-18 against Fas-mediated liver injury.

K. Shiraki, Y. Takei, K. Sugimoto, 2008, International journal of molecular medicine.

Primary biliary cirrhosis after aortoiliac reconstruction surgery using a Y-graft: A case report

K. Shiraki, T. Nakano, K. Sugimoto, 2005 .

Computed tomographic image of an inflammatory fibroid polyp of the stomach.

K. Shiraki, T. Nakano, H. Yoshimura, 2003, Clinical imaging.

Hepatic portal venous gas caused by non-obstructive mesenteric ischemia.

K. Shiraki, H. Fuke, A. Hashimoto, 2002, Journal of hepatology.

Matrix metalloproteinase, hepatocyte growth factor, and tissue inhibitor of matrix metalloproteinase during human liver regeneration

K. Shiraki, T. Nakano, S. Uemoto, 2006, Liver international (Print).

Predictive factors for distant recurrence of HCV‐related hepatocellular carcinoma after radiofrequency ablation combined with chemoembolization

K. Takeda, H. Takaki, K. Yamakado, 2008, Alimentary pharmacology & therapeutics.

Gastric varix associated with autoimmune pancreatitis.

K. Shiraki, H. Fuke, A. Shimizu, 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas 5 cm or smaller: risk factors for local tumor progression.

K. Takeda, H. Takaki, K. Yamakado, 2007, Journal of vascular and interventional radiology : JVIR.

Macrocytic anemia during low-dose cisplatin and 5-Fluorouracil through implanted infusion port for unresectable hepatobilliary malignancies.

K. Shiraki, T. Nakano, K. Sugimoto, 2005, Anticancer research.